WWW.DISSERTATION.XLIBX.INFO
FREE ELECTRONIC LIBRARY - Dissertations, online materials
 
<< HOME
CONTACTS



«GDHC191DFR / Published July 2013 Executive Summary Below table provides a summary of the key metrics for The strong late-stage pipeline is set to ...»

Cyclokat (Dry Eye Syndrome)

Forecast and Market Analysis to 2022

GDHC191DFR / Published July 2013

Executive Summary

Below table provides a summary of the key metrics for The strong late-stage pipeline is set to offer a strong

Cyclokat in the major pharmaceuticals markets. competition to Cyclokat.

Potential generic Restasis will prove detrimental to

Cyclokat: Key Metrics in the Major Pharmaceutical Markets, 2012 - 2022 Cyclokat uptake in the US, since they both have the 2022 Market Sales same active ingredient.

US $87.6m 5EU $518.0m Below figure illustrates Cyclokat sales during the forecast Total Global* $605.6m period.

Key events (2012-2022) Level of Impact Cyclokat launch in the US in 2016 ↑ Sales of Cyclokat by Region, 2022 Cyclokat launch in the 5EU in 2014 ↑↑ *For the purposes of this report, Global = US, France, Germany, Italy, Spain, UK 2022 14.5% Source: GlobalData Total: $605.6m NA: Not Applicable Sales of Cyclokat in the Global Dry Eye Syndrome US Market 5EU GlobalData expects Cyclokat to launch in the US

–  –  –

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Catalyst

2.2 Related Reports

3 Disease Overview

3.1 Etiology and Pathophysiology

3.1.1 Etiology

3.1.2 Pathophysiology

3.1.3 Classification

3.1.4 Prognosis

3.1.5 Quality of Life

3.2 Symptoms

4 Disease Management

4.1 Overview

4.1.1 Diagnosis Overview

4.1.2 Treatment Guidelines

4.1.3 Treatment Overview

5 Competitive Assessment

5.1 Overview

5.2 Strategic Competitor Assessment

6 Opportunity and Unmet Need

6.1 Overview

6.2 Diagnostic tests are not specific enough to identify subgroups of patients..................32

6.3 Frequent dosing and side effects limit compliance

6.4 Lack of physician and patient awareness

–  –  –

6.5 Trial design may be a factor in so few drugs being approved

6.6 Unmet Needs Gap Analysis

6.7 Comprehensive method for measuring dry eye signs and severity levels

6.8 Increase treatment rates among milder forms of the disease

7 Pipeline Assessment

7.1 Overview

7.2 Promising drugs in clinical development

8 Cyclokat

8.1 Overview

8.2 Efficacy

8.3 Safety

8.4 Dosing and Formulation

8.5 Potential Clinical Positioning

8.6 Potential Commercial Positioning

8.7 Pricing and Reimbursement

8.8 SWOT Analysis

8.9 Forecast

9 Appendix

9.1 Bibliography

9.2 Abbreviations

9.3 Methodology

9.4 Forecasting Methodology

9.4.1 Diagnosed DES patients

9.4.2 Percent Drug-treated Patients

9.4.3 General Pricing Assumptions

9.4.4 Individual Drug Assumptions

9.4.5 Generic Erosion

9.5 Physicians and Specialists Included in this Study

–  –  –

9.6 About the Authors

9.6.1 Author

9.6.2 Global Head of Healthcare

9.7 About GlobalData

9.8 Contact Us

9.9 Disclaimer

–  –  –

Table 1: Symptoms of Dry Eye Syndrome

Table 2: Treatment Guidelines for Dry Eye Syndrome

Table 3: Commonly Prescribed Drugs for Dry Eye Syndrome by Class in the Global Markets, 2012

Table 4: Leading Treatments for Dry Eye Syndrome, 2012

Table 5: Overall Unmet Needs – Current Level of Attainment

Table 6: Clinical Unmet Needs – Gap Analysis, 2012

Table 7: Dry Eye Syndrome – Phase Pipeline, 2012

Table 8: Comparison of Therapeutic Classes in Development for Dry Eye Syndrome, 2012........41 Table 9: Product Profile – Cyclokat

Table 10: Cyclokat SWOT Analysis, 2012

Table 11: Global Sales Forecasts ($m) for Cyclokat, 2012–2022

–  –  –

Figure 1: Dry Eye Syndrome – Disease Etiology

Figure 2: Tear Film in Normal Eye and Dry Eye

Figure 3: Sequence of Diagnostic Tests Used to Diagnose Dry Eye Syndrome

Figure 4: Delphi Panel Treatment Recommendations for Dysfunctional Tear Syndrome Without Lid Margin Disease, 2006

Figure 5: Delphi Panel Treatment Recommendations for Dysfunctional Tear Syndrome With Lid Margin Disease and Abnormal Tear Distribution, 2006

Figure 6: Treatment Recommendations for Dry Eye Syndrome from the Management and Therapy Subcommittee, Dry Eye Workshop, 2007

Figure 7: American Academy of Ophthalmology Preferred Practice Pattern for Dry Eye, 2011......25 Figure 8: Competitive Assessment of Late-Stage Pipeline Agents in Dry Eye Syndrome, 2012– 2022

–  –  –

This report provides a thorough analysis of the current and future landscape of DES therapeutics.

For this report, the global coverage includes the seven major markets (7MM), US, UK, Germany, France, Italy, Spain, UK, and Japan, as well as the emerging markets of China and India. Artificial tears are the mainstay of therapy for the treatment of dry eye, regardless of severity of the disease, along with other pharmacologic treatment options, including Restasis (cyclosporine 0.05% ophthalmic emulsion), Diquas (diquafosol tetrasodium), and Mucosta (2% rebamipide ophthalmic suspension). The DES pipeline is strong, with 49 molecules in various phases of development.

More notably, the late-stage pipeline has three products with novel mechanisms of action to treat the inflammation associated with the disease.

Since the last GlobalData DES report, in addition to a consistently growing patient population as a result of aging baby boomers and lifestyle changes associated with increased industrialization, two new entrants have emerged in the DES market: Diquas and Mucosta. Both have been launched in Japan and are contributing significantly to the treatment paradigm and will continue to capture market share.

–  –  –

GlobalData is a leading global provider of business intelligence in the Healthcare industry.

GlobalData provides its clients with up-to-date information and analysis on the latest developments in drug research, disease analysis, and clinical research and development. Our integrated business intelligence solutions include a range of interactive online databases, analytical tools, reports and forecasts. Our analysis is supported by a 24/7 client support and analyst team.

GlobalData has offices in New York, Boston, London, India and Singapore.

–  –  –

No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior permission of the publisher, GlobalData.

© GlobalData.

This report is a licensed product and is not to be copied, reproduced, shared or resold in any form.

Page 57 GDHC191DFR / Published JULY 2013



Similar works:

«B2B Remittance Data – Challenges and Solutions Discussion Paper Contents 1. Introduction 2. The Remittance Data Challenge 3. Current and Proposed Solutions Landscape 3.1. Short Form Solutions 3.2. Extended Remittance Data Solutions 4. Recommendations and observations Annex 1 – Summary of Remittance Data Methods 1. Introduction This paper assesses the current remittance data situation in B2B payments and opportunities to facilitate end-to-end reconciliation by payment receivers. Specifically...»

«International Journal of Humanities and Social Science Vol. 2 No. 22 [Special Issue – November 2012] African Literature in a Structural and Linguistic Jail: Acknowledging, Apprehending and Advocating for Prison Break Dr. John Mugubi, PhD Chairman Department of Theatre Arts and Film Technology Kenyatta University P.O. Box 43844-00100, Nairobi, Kenya. “Matter is expressed in manner” The above words by Wordsworth succinctly capture the inextricable relationship between form and content. That...»

«NDA 019010/S-036 Lupron (leuprolide acetate) Injection Reference ID: 2888059 LUPRON leuprolide acetate injection, solution Abbott Laboratories LUPRON® INJECTION (leuprolide acetate) Rx only DESCRIPTION Leuprolide acetate is a synthetic nonapeptide analog of naturally occurring gonadotropin releasing hormone (GnRH or LH-RH). The analog possesses greater potency than the natural hormone. The chemical name is...»

«Connections Day 2016 | Question & Answer Academics, Classwork, and Grades | p. 1 Alcohol and Other Drugs | p. 3 Athletics | p. 4 Cars and Parking | p. 5 Clubs and Organizations | p. 5 Greek Life | p. 6 Orientation | p. 7 Recreation | p. 8 Residence Life and Housing | p. 9 Safety | p. 11 Work Study and Jobs After Redlands | p. 14 Additional Resources and Miscellaneous Questions | p. 14 Academics, Classwork, and Grades After you use your two included May Terms can you still go on a May Term study...»

«Technical Documentation Predictor-LimA Type 7810 Valid from Version 9.0 Installation Manual English BE 1486 – 25 Predictor-LimA Type 7810 Valid from Version 9.0 Installation Manual October 2012 BE 148625 Trademarks Microsoft and Windows are registered trademarks of Microsoft Corporation · Intel is a registered trademark and Core is a trademark of Intel Corporation or its subsidiaries in the United States and/ or other countries · OpenGL is a registered trademark of Silicon Graphics, Inc....»

«Body Ritual among the Nacirema Author(s): Horace Miner Reviewed work(s): Source: American Anthropologist, New Series, Vol. 58, No. 3 (Jun., 1956), pp. 503-507 Published by: Wiley-Blackwell on behalf of the American Anthropological Association Stable URL: http://www.jstor.org/stable/665280. Accessed: 21/08/2012 16:44 Your use of the JSTOR archive indicates your acceptance of the Terms & Conditions of Use, available at. http://www.jstor.org/page/info/about/policies/terms.jsp. JSTOR is a...»

«Bendectin How a Commonly Used Drug Caused Birth Defects Part One by Betty Mekdeci Executive Director Birth Defect Research for Children Nausea and occasional vomiting is often one of the first symptoms heralding pregnancy. It is a discomfort women have coped with for millennia. Up to 50% of all pregnant women may experience these symptoms at some time during pregnancy. Although popularly called morning sickness, the condition may also occur in the evening or throughout the day. The precise...»

«1 „Das Leben ist ein Fragment“1 (Bonhoeffer) KLOSTER STIPEL, 10. September 2007, 20.00 Uhr Elisabeth Jünemann „Das Leben ist ein Fragment.“ – Wer spricht einen solchen Satz? Der, der nachdenkt über sein Leben? Und das der anderen? Und zu dem Schluss kommt, dass das Leben nie ganz ist, nie vollkommen und rund? Weil es jedenfalls ein Ende hat? Weil es jedenfalls vom Tod betroffen ist? „Das Leben ist ein Fragment.“ – Wer spricht einen solchen Satz? Der, der nachdenkt über den...»

«José Martínez Hernández La teoría estética de Federico García Lorca La teoría estética de Federico García Lorca José Martínez Hernández * Universidad de Murcia La poesía y el teatro de Federico García Lorca son, como es notorio, universalmente conocidos, admirados y estudiados por su grandeza y originalidad. Sin embargo, no ocurre lo mismo con el pensamiento estético que subyace a sus geniales creaciones poéticas y dramáticas, que sólo ocasionalmente ha merecido la atención...»

«Zoran Ilievski Country Specific Report: Macedonia The Role of Human and Minority Rights in the Process of Reconstruction and Reconciliation for State and Nation-Building: Macedonia This report was compiled in the frame of the FP6 project “Human and Minority Rights in the Life Cycle of Ethnic Conflicts”. The author was affiliated to the European Academy of Bolzano/Bozen (Italy) one of the partners in this project. Copyright February 2008: the executing contracting institution Country...»

«Jabotinsky.The Man and the Vision William Mehlman A Publication of Americans For A Safe Israel Foreword Seven decades have passed since the death of Ze’ev Jabotinsky. In that time great and terrible events have transpired to reshape Jewish life and thought: A third of our people perished in the camps and crematoria of Eastern and Central Europe; a Jewish state was reborn and has fought seven wars for its continued existence, and an ingathering into Israel of the exiles began that has already...»

«2 Rue de la Charité Giorgio Fabbri 13002 Marseille giorgio.fabbri@univ-amu.fr http://sites.google.com/site/giorgiofabbri1979/ Curriculum vitæ —. Born in Cesena (Italy), 10 Apr 1979 14th of October 2016 Education and positions Chargé de Recherche (CR2), CNRS, Labo d’affectation : GREQAM (Groupement de Oct 2015 Today Recherche en Économie Quantitative d’Aix-Marseille), Marseille, France. PRAS (PRofesseur ASssocié), University “d’Evry Val d’Essonne”, Evry, France. Department...»





 
<<  HOME   |    CONTACTS
2016 www.dissertation.xlibx.info - Dissertations, online materials

Materials of this site are available for review, all rights belong to their respective owners.
If you do not agree with the fact that your material is placed on this site, please, email us, we will within 1-2 business days delete him.